May 8, 2018 / 10:40 AM / in 6 months

Drugmaker Endo posts wider quarterly loss

May 8 (Reuters) - Drugmaker Endo International Plc reported a bigger quarterly loss on Tuesday, hurt by an impairment charge and a fall in sales of its generic drugs.

The company recorded an asset impairment charge of $448.4 million.

Net loss attributable to shareholders was $505.5 million, or $2.26 per share in the first quarter ended March 31, compared with a loss of $173.8 million or 78 cents per share a year earlier.

Revenue fell to $700.5 million from $1.04 billion. (Reporting by Tamara Mathias in Bengaluru; Editing by Shailesh Kuber)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below